![Meiyi Xia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Meiyi Xia
Corporate Officer/Principal bij
Spring Asset Management LLC
Profiel
Meiyi Xia has been Vice President of China Medicine Corp.
since March 22, 2006.
She has been a Partner of Princeton Capital Group since January 2006 and a Partner of Spring Asset Management LLC since September 2004.
Ms. Xia was President of China Medicine from February 8, 2006 to March 21, 20006 and a Director from February 7 to February 10, 2006.
She was Chief Executive Officer of AiDi Financial Investment LLC from January 2003 to December 2005.
Ms. Xia was a Financial Advisor of Morgan Stanley from July 2002 to January 2003 and President of Asia Pacific Consulting and Asia Pacific Securities from January 1999 to June 2002.
She received her MBA from Long Island University and a Diploma of Graduate School in Financial Management from Scuola Mattei, Milan, Italy.
Actieve functies van Meiyi Xia
| Bedrijven | Functie | Begin |
|---|---|---|
Spring Asset Management LLC | Corporate Officer/Principal | 01-09-2004 |
Eerdere bekende functies van Meiyi Xia
| Bedrijven | Functie | Einde |
|---|---|---|
| CHINA MED | Corporate Officer/Principal | 01-09-2007 |
AiDi Financial Investment LLC | President | 01-12-2005 |
Asia Pacific Consulting & Asia Pacific Securities | President | 01-06-2002 |
Opleiding van Meiyi Xia
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Medicine Corp.
 China Medicine Corp. Pharmaceuticals: MajorHealth Technology Engages in research & development, manufacture and wholesale of prescription and over the counter pharmaceuticals and traditional Chinese medicines | Health Technology |
Spring Asset Management LLC | |
AiDi Financial Investment LLC | |
Asia Pacific Consulting & Asia Pacific Securities |
Kies MarketScreener 
